Cargando…
Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyond
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant state for a spectrum of lymphoplasmacytic malignancies. The risk of progression of MGUS to a symptomatic therapy requiring plasma cell dyscrasia is about 1% per year. Studies carried out over the previous 10 years have impro...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Faculty Opinions Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720897/ https://www.ncbi.nlm.nih.gov/pubmed/36532706 http://dx.doi.org/10.12703/r/11-34 |